cyanides has been researched along with Angiogenesis, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azarbayjani, F; Christofferson, R; Fuchs, D; Lindhagen, E; Stridsberg, M | 1 |
| Bäckman, U; Christofferson, R; Jonsson, E; Larsson, R; Svensson, A | 1 |
2 other study(ies) available for cyanides and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Regression of orthotopic neuroblastoma in mice by targeting the endothelial and tumor cell compartments.
Topics: Animals; Autopsy; Calgranulin A; Cell Compartmentation; Cell Line, Tumor; Cyanides; Endothelial Cells; Fibroblasts; Guanidines; Humans; Liver Neoplasms; Mice; Mice, SCID; Neoplasm Metastasis; Neovascularization, Pathologic; Neuroblastoma; Remission Induction; Risk Factors; Xenograft Model Antitumor Assays | 2009 |
CHS 828 inhibits neuroblastoma growth in mice alone and in combination with antiangiogenic drugs.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Division; Cyanides; Cyclohexanes; Guanidines; Humans; Indoles; Male; Mice; Mice, Nude; Neovascularization, Pathologic; Neuroblastoma; O-(Chloroacetylcarbamoyl)fumagillol; Pyrroles; Remission Induction; Sesquiterpenes; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2002 |